Following a full submission
AWMSG advice |
||
| Status: Recommended | ||
The Minister for Health & Social Services has endorsed AWMSG's recommendation to support the treatment of neonates and children suffering from urea cycle disorders with sodium phenylbutyrate within NHS Wales in accordance with appropriate peer-reviewed guidelines. |
||
|
||
Medicine details |
||
| Medicine name | sodium phenylbutyrate (Ammonaps®) | |
| Formulation | 500 mg tablet, 940 mg/g granules | |
| Reference number | 280 | |
| Indication | Adjunctive therapy in the chronic management of urea cycle disorders in neonatal onset presentation or in patients with late-onset disease and a history of hyperammonaemic encephalopathy |
|
| Company | Orphan Europe (UK) Ltd | |
| BNF chapter | Nutrition & blood | |
| Assessment type | Full | |
| Status | Recommended | |
| AWMSG meeting date | 02/03/2004 | |
| Ratification by Welsh Government | 14/05/2004 | |
| Date of issue | 25/05/2004 | |